Evofem’s PHEXX® Receives Pricing Certificates in UAE, Paving Way for Launch Evofem Biosciences announces the issuance of favorable pricing certificates for PHEXX® in the UAE, a crucial step towards its 2026 commercial launch.

Evofem’s PHEXX® Receives Pricing Certificates in UAE, Paving Way for Launch #Dubai #UAE #Pharma_1 #Evofem #PHEXX

Evofem's SOLOSEC Approved for Launch in the UAE for Women's Health Evofem's innovative treatment, SOLOSEC®, targets bacterial vaginosis and trichomoniasis, aiming for a 2026 launch in the UAE. Discover more about this significant advancement in women's health.

Evofem's SOLOSEC Approved for Launch in the UAE for Women's Health #Abu_Dhabi #United_Arab_Emirates #SOLOSEC #Pharma_1 #Evofem

Evofem's Hormone-Free Contraceptive PHEXXI Heads to UAE Market Approval Evofem Biosciences partners with Pharma 1 to seek UAE marketing approval for PHEXXI, a hormone-free contraceptive set to launch in 2026.

Evofem's Hormone-Free Contraceptive PHEXXI Heads to UAE Market Approval #United_Arab_Emirates #Dubai #Evofem_Biosciences #PHEXXI #Pharma_1

Evofem and Pharma 1 Form Partnership to Launch SOLOSEC in the Middle East Evofem Biosciences has entered a partnership with Pharma 1 to license SOLOSEC in the Middle East, addressing key women's health needs.

Evofem and Pharma 1 Form Partnership to Launch SOLOSEC in the Middle East #Abu_Dhabi #United_Arab_Emirates #Evofem_Biosciences #SOLOSEC #Pharma_1